Vytrus Biotech, S.A. (BME:VYT)

Vytrus Biotech Revenue

Vytrus Biotech had revenue of 3.03M EUR in the half year ending June 30, 2024, with 26.54% growth. This brings the company's revenue in the last twelve months to 5.24M, up 14.24% year-over-year. In the year 2023, Vytrus Biotech had annual revenue of 4.70M with 4.90% growth.

• Revenue (ttm): 5.24M
• Revenue Growth: +14.24%
• P/S Ratio: 5.87
• Revenue / Employee: 149.64K
• Employees: 35
• Market Cap: 30.77M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	4.70M	219.70K	4.90%
Dec 31, 2022	4.48M	968.83K	27.57%
Dec 31, 2021	3.51M	1.28M	57.47%
Dec 31, 2020	2.23M	456.81K	25.74%
Dec 31, 2019	1.77M	504.23K	39.69%